forane 100% płyn do sporządzania inhalacji parowej
abbvie polska sp. z o.o. - isofluranum - płyn do sporządzania inhalacji parowej - 100%
survanta 25 mg/ml zawiesina do podawania dotchawiczego
abbvie polska sp. z o.o. - beractantum - zawiesina do podawania dotchawiczego - 25 mg/ml
sevorane 100% płyn wziewny
abbvie sp. z o.o. - sevofluranum - płyn wziewny - 100%
duodopa 20 mg/ml + 5 mg/ml Żel dojelitowy
abbvie sp. z o.o. - levodopum + carbidopum - Żel dojelitowy - 20 mg/ml + 5 mg/ml
combigan (2 mg + 5 mg)/ml krople do oczu
abbvie sp. z o.o. - thymolum + brimonidini tartras - krople do oczu - (2 mg + 5 mg)/ml
vistabel 4 j. allergan/0,1 ml proszek do sporządzania roztworu do wstrzykiwań
abbvie sp. z o.o. - toxinum botulinicum typum a ad iniectabile - proszek do sporządzania roztworu do wstrzykiwań - 4 j. allergan/0,1 ml
moderiba 200 mg tabletki powlekane
abbvie polska sp. z o.o. - povidonum + ribavirinum - tabletki powlekane - 200 mg
moderiba 400 mg tabletki powlekane
abbvie polska sp. z o.o. - ribavirinum - tabletki powlekane - 400 mg
moderiba 600 mg tabletki powlekane
abbvie polska sp. z o.o. - ribavirinum - tabletki powlekane - 600 mg
skyrizi
abbvie deutschland gmbh & co. kg - risankizumab - psoriasis; arthritis, psoriatic - leki immunosupresyjne - plaque psoriasisskyrizi is indicated for the treatment of moderate to severe plaque psoriasis in adults who are candidates for systemic therapy. psoriatic arthritisskyrizi, alone or in combination with methotrexate (mtx), is indicated for the treatment of active psoriatic arthritis in adults who have had an inadequate response or who have been intolerant to one or more disease-modifying antirheumatic drugs (dmards). crohn's diseaseskyrizi is indicated for the treatment of adult patients with moderately to severely active crohn's disease who have had an inadequate response to, lost response to, or were intolerant to conventional therapy or a biologic therapy.